Humana backs FY23 adjusted EPS view to ‘at least’ $28.25, consensus $28.30

Raises 2023 individual Medicare Advantage membership growth by 35,000 to ‘approximately 860,000’, or 19 percent growth over FY 2022 ending membership, meaningfully higher than industry growth. Anticipates 2024 individual Medicare Advantage membership growth at or above industry growth level. Achieves 94 percent of the company’s Medicare Advantage members currently enrolled in 4-star and above contracts for 2024, an industry-leader among its publicly traded peers for the sixth consecutive year; 61 percent of members in 4.5 and 5-star contracts.